eli lilly

An experimental eli lilly gene-editing drug sharply lowers LDL cholesterol in an early trial, raising hopes of a one-time treatment for high-risk heart patients, but larger studies must still prove long-term safety

A groundbreaking gene therapy, VERVE-102, has shown promise in reducing "bad" cholesterol by up to 62% with a single injection, potentially transforming heart health treatment. This one-off infusion targets the liver's cholesterol production, offering a sustained solution for patients struggling with daily medication adherence and side effects.

German researchers are making waves with a cutting-edge 'Trojan horse' obesity drug that has eclipsed current frontrunners in trials with mice. The innovative formula decreases appetite and weight significantly while also enhancing blood sugar levels and insulin sensitivity. Utilizing hormone mimics for precise cellular targeting, this approach minimizes unwanted side effects and presents a multifaceted method for combating obesity.

A man in Gurgaon was allegedly producing fake Mounjaro injections and selling his own unapproved brand, 'Toneup', disguised as a Japanese product. Authorities recalled 22 Toneup injections after tracing sales to multiple cities. The accused learned to make injections using online resources and sourced materials from China.

Lower-cost, latest-generation immunotherapies from China are a shot in the arm for Indian cancer patients who have been priced out of treatment by expensive drugs from western MNCs

Raw Material Source Tracked, Flat In Gurgaon Used to Assemble Injections

Authorities have uncovered a dual operation in Gurgaon where a man manufactured fake Mounjaro injections and an unapproved tirzepatide-based product named 'Toneup'. Using 3D printing for packaging, he sold these counterfeit and unapproved vials online, with some traced to buyers in Delhi and Hyderabad. The investigation is ongoing, and an immediate recall has been initiated.

Affordable generic versions of Ozempic and Wegovy have quickly secured 20% of the Rs 1,600 crore weight-loss market following patent expiry. Early movers like Torrent and Sun Pharma are challenging eli lilly's Mounjaro, with generics and lower pricing boosting semaglutide's market position.

The UAE has approved Foundayo (orforglipron), eli lilly's once-daily oral obesity pill, becoming one of the first countries globally to offer a needle-free alternative. This GLP-1 receptor agonist mimics natural hormones to regulate appetite and blood sugar, aiding weight loss and improving metabolic health. Available by prescription from May 2026, it's intended for long-term use alongside lifestyle changes.

It is not a quick fix. It is not your ‘next-generation weight-loss drug’. It is not a cosmetic solution or something to include in a pre-wedding routine, experts warn. Despite that, the popularity of Mounjaro continues to quietly reshape the narrative around fitness, beauty and confidence

NEW DELHI: US-based pharmaceutical company eli lilly and company is close to inking a deal with two companies to globally source gastrointestinal and tuberculosis bulk drugs from India, a top company official said on Friday.

Sun Pharma on Thursday claimed victory over eli lilly and Co in a patent litigation over Gemzar, used in cancer treatment, with a US federal court ruling in its favour.

NEW DELHI: eli lilly is planning to make India a major sourcing base for global supply of drugs. The pharmaceutical MNC has also identified a suit of patented cancer and diabetes drugs, currently under development in the US, to launch in the Indian market post 2005.

MUMBAI: Ranbaxy Laboratories' management has decided to divest its stake from eli lilly Ranbaxy Ltd. The company has also decided to to take stake in Gufic Pharma from its promoters. The company, it is learnt has already acquired 17 brands from the company.

MUMBAI: Ranbaxy Laboratories' management has decided to divest its stake from eli lilly Ranbaxy Ltd. The company has also decided to to take stake in Gufic Pharma from its promoters. The company, it is learnt has already acquired 17 brands from the company.

BANGALORE: eli lilly India on Wednesday launched a new drug for juvenile diabetics, even as it declared that it would not start an insulin price war, with Wockhardt dropping the rates earlier this week.